The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of Janus kinase 1 (JAK1) inhibitor itacitinib for treatment-refractory sarcomas: Leiomyosarcoma cohort.
 
Michael Wagner
Consulting or Advisory Role - AADi; Boehringer Ingelheim; Deciphera; Pharmaessentia; SpringWorks Therapeutics
Research Funding - Adaptimmune (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); Incyte (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Cogent Biosciences; Cogent Biosciences
 
Lee Cranmer
Consulting or Advisory Role - SpringWorks Therapeutics
Research Funding - AADi; AADi (Inst); Advenchen Laboratories (Inst); Avacta Life Sciences (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); InhibRx (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Merck (Inst); Monopar Therapeutics (Inst); Philogen (Inst); Salarius Pharmaceuticals (Inst); Salarius Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Elizabeth Loggers
Research Funding - Adaptimmune (Inst); AmMax Bio (Inst); Avacta Life Sciences (Inst); Ayala Pharmaceuticals (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); Dicephera Pharmaceuticals, Inc. (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); SpringWorks Therapeutics (Inst)
 
Roxanne Moore
No Relationships to Disclose
 
Shannon Hill
No Relationships to Disclose
 
Anirudh Goyal
No Relationships to Disclose
 
Munther Baroudi
No Relationships to Disclose
 
Niall Morin
No Relationships to Disclose
 
Rylee Johnson
No Relationships to Disclose
 
Kimberly Smythe
No Relationships to Disclose
 
Lauri Aicher
No Relationships to Disclose
 
Cecilia Yeung
Consulting or Advisory Role - DiaCarta; OBI Pharma
Speakers' Bureau - Archer
Research Funding - Pfizer (Inst)
 
Seth Pollack
Consulting or Advisory Role - AADi; Apexigen; Bayer; Daiichi Sankyo; Deciphera; Epizyme; GlaxoSmithKline; Obsidian Therapeutics; Sensei Biotherapeutics; T-knife Therapeutics
Speakers' Bureau - Deciphera